ScholarGate
Asistents

Salīdzināt metodes

Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.

EDSS: Kurtzke paplašinātā invaliditātes skalas×NIHSS: Nacionālo veselības institūtu insultu skala×RMI: Rivermead Mobility Index×
NozareNeiroloģijaNeiroloģijaNeiroloģija
SaimeProcess / pipelineProcess / pipelineProcess / pipeline
Izcelsmes gads198319891991
AutorsJohn F. KurtzkeThomas Brott and NIH Stroke Study GroupFrank Collen, Derick Wade, and Rivermead Rehabilitation Centre
TipsClinician-ratedClinician-ratedClinician-observed performance test
PirmavotsKurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444-1452. DOI ↗Brott, T., Adams, H. P., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864-870. DOI ↗Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54. DOI ↗
Citi nosaukumiExpanded Disability Status ScaleNIH Stroke ScaleRivermead Mobility Index
Saistītās455
KopsavilkumsThe EDSS is the most widely used clinical disability rating scale in multiple sclerosis research and practice. Developed by John Kurtzke in 1983, it provides a 0-10 ordinal scale capturing disease severity across eight neurological functional systems and functional status. The EDSS remains the primary endpoint in MS clinical trials and longitudinal cohort studies, with decades of prognostic and comparative data worldwide.The NIHSS is the standard acute stroke severity assessment tool used in emergency departments, stroke centers, and clinical trials worldwide. Developed by the NIH Stroke Study Group in 1989, the 15-item scale provides rapid, reproducible quantification of acute neurological deficit from ischemic or hemorrhagic stroke. NIHSS scores inform thrombolytic and thrombectomy eligibility, predict outcomes, and serve as primary endpoint in stroke intervention trials.The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes.
ScholarGateDatu kopa
  1. v1
  2. 1 Avoti
  3. PUBLISHED
  1. v1
  2. 1 Avoti
  3. PUBLISHED
  1. v1
  2. 1 Avoti
  3. PUBLISHED

Doties uz meklēšanu Lejupielādēt slaidus

ScholarGateSalīdzināt metodes: EDSS · NIHSS · RMI. Izgūts 2026-06-19 no https://scholargate.app/lv/compare